EPD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
["Buy now: fundamentals and sentiment support upside despite a currently weak/late-stage technical setup.", "Near-term setup favors a steadier, income-driven move (distribution growth + cash flow) rather than a fast momentum breakout.", "Street price targets moved up meaningfully (to ~$38\u2013$39 at top-tier firms), implying upside from ~35.17 with a supportive catalyst backdrop (Q4 beat, multi-year growth commentary).", "No Intellectia edge today (no AI Stock Picker / SwingMax), so the decision leans on catalysts + options sentiment + analyst revisions."]
["Trend/Momentum: Bearish structure with SMA_200 > SMA_20 > SMA_5, indicating price has been trading below key trend averages.", "MACD: Histogram -0.00766 and negatively expanding, consistent with fading momentum and a down/soft tape.", "RSI(6): 38.1, leaning toward weak/near-oversold conditions (not a confirmed reversal signal, but pressure may be late-cycle).", "Levels: Provided pivot/support cluster is around 31.1\u201331.4 (S1/Pivot), implying a meaningful downside reference if weakness persists; near-term upside reference is better framed by analyst targets (36\u201339) given current price is well above the provided R-levels.", "Pattern-based forward drift: model indicates mild near-term chop (next day slightly negative) but positive bias over 1 week (+3.79%) and 1 month (+2.16%).", "Intellectia Proprietary Trading Signals: - AI Stock Picker: No signal on given stock today. - SwingMax: No signal on given stock recently."]
["Q4/2025 results highlighted record performance: record Q4 EBITDA ($2.7B) and record 2025 adjusted cash flow ($8.7B).", "Distribution increase to $0.55/common unit reinforces income appeal and confidence in cash generation.", "Growth capex program continues (2025: $4.4B; 2026 planned: $2.5B\u2013$2.9B), supporting multi-year project ramp.", "Macro tailwinds referenced by analysts: power demand + LNG export growth improving midstream opportunity set."]
citing limited re-rate catalysts without stronger growth, and Jefferies remains Hold (PT ~$
despite acknowledging improved multi-year guidance.", "Financial mix: revenue down YoY and gross margin compressed sharply, which can temper multiple expansion if persistent."]
["Latest quarter: 2025/Q4.", "Revenue: $13.793B, down -2.87% YoY (top-line softness).", "Net income: $1.644B, up +2.49% YoY (profitability held up).", "EPS: $0.75, up +1.35% YoY (modest per-unit growth).", "Gross margin: 14.5%, down -31.05% YoY (notable compression; watch whether it stabilizes as projects ramp)."]
["Recent trend: clear positive revision cycle on 2026-02-04 with multiple price target raises after Q4 beat/growth commentary.", "Bull case (pros): Barclays Overweight PT $38 (from $35) and Citi Buy PT $39 (from $36) point to improving multi-year growth profile and stronger outlook.", "Bear/neutral case (cons): Jefferies stays Hold (PT $34) questioning whether FY27 guidance embeds aggressive commodity/spread assumptions; Morgan Stanley previously downgraded to Underweight (PT $34) on limited re-rating catalysts.", "Net take: Wall Street is leaning constructive overall (more upward PT revisions than cuts), but not unanimous\u2014upside case relies on execution and delivery of the guided multi-year ramp.", "Influential/political flows: Hedge funds neutral; insiders neutral; no recent Congress trading data available."]
